ITCH K63-Ubiquitinates the NOD2 Binding Protein, RIP2, to Influence Inflammatory Signaling Pathways

Current Biology

Volumn 19, Issue 15, 2009, Pages 1255-1263

  Tao, MingFang ^a   Scacheri, Peter C ^a   Marinis, Jill M ^a   Harhaj, Edward W ^b   Matesic, Lydia E ^c   Abbott, Derek W ^a  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MIAMI   (United States)

^c UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

MOLIMMUNOL; SIGNALING

Indexed keywords

CASPASE RECRUITMENT DOMAIN PROTEIN 15; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; ITCH PROTEIN, HUMAN; N ACETYLMURAMYLALANYL DEXTRO ISOGLUTAMINE; NOD2 PROTEIN, HUMAN; RECEPTOR INTERACTING PROTEIN SERINE THREONINE KINASE 2; REPRESSOR PROTEIN; RIPK2 PROTEIN, HUMAN; SMALL INTERFERING RNA; UBIQUITIN PROTEIN LIGASE;

ARTICLE; CELL LINE; CROHN DISEASE; DNA MICROARRAY; GENETICS; HUMAN; IMMUNOBLOTTING; IMMUNOPRECIPITATION; LISTERIA MONOCYTOGENES; METABOLISM; PHYSIOLOGY; SIGNAL TRANSDUCTION; UBIQUITINATION;

ACETYLMURAMYL-ALANYL-ISOGLUTAMINE; CELL LINE; CROHN DISEASE; HUMANS; IMMUNOBLOTTING; IMMUNOPRECIPITATION; LISTERIA MONOCYTOGENES; NF-KAPPA B; NOD2 SIGNALING ADAPTOR PROTEIN; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; RECEPTOR-INTERACTING PROTEIN SERINE-THREONINE KINASE 2; REPRESSOR PROTEINS; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; UBIQUITIN-PROTEIN LIGASES; UBIQUITINATION;

BACTERIA (MICROORGANISMS); LISTERIA MONOCYTOGENES;

EID: 68149170034     PISSN: 09609822     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cub.2009.06.038     Document Type: Article

References (40)

1. Inohara N., Chamaillard M., McDonald C., and Nunez G. NOD-LRR proteins: role in host-microbial interactions and inflammatory disease. Annu. Rev. Biochem. 74 (2005) 355-383
2. Fritz J.H., Ferrero R.L., Philpott D.J., and Girardin S.E. Nod-like proteins in immunity, inflammation and disease. Nat. Immunol. 7 (2006) 1250-1257
3. Strober W., Murray P.J., Kitani A., and Watanabe T. Signalling pathways and molecular interactions of NOD1 and NOD2. Nat. Rev. Immunol. 6 (2006) 9-21
4. Kanneganti T.D., Lamkanfi M., and Núñez G. Intracellular NOD-like receptors in host defense and disease. Immunity 27 (2007) 549-559
5. Henckaerts L., and Vermeire S. NOD2/CARD15 disease associations other than Crohn's disease. Inflamm. Bowel Dis. 13 (2007) 235-241
6. Inohara N., Koseki T., Lin J., del Peso L., Lucas P.C., Chen F.F., Ogura Y., and Núñez G. An induced proximity model for NF-kappa B activation in the Nod1/RICK and RIP signaling pathways. J. Biol. Chem. 275 (2000) 27823-27831
7. Abbott D.W., Wilkins A., Asara J.M., and Cantley L.C. The Crohn's disease protein, NOD2, requires RIP2 in order to induce ubiquitinylation of a novel site on NEMO. Curr. Biol. 14 (2004) 2217-2227
8. Abbott D.W., Yang Y., Hutti J.E., Madhavarapu S., Kelliher M.A., and Cantley L.C. Coordinated Regulation of Toll-Like Receptor and NOD2 Signaling by K63-Linked Polyubiquitin Chains. Mol. Cell. Biol. 27 (2007) 6012-6025
9. Girardin S.E., Boneca I.G., Viala J., Chamaillard M., Labigne A., Thomas G., Philpott D.J., and Sansonetti P.J. Nod2 is a general sensor of peptidoglycan through muramyl dipeptide (MDP) detection. J. Biol. Chem. 278 (2003) 8869-8872
10. Inohara N., et al. Host recognition of bacterial muramyl dipeptide mediated through NOD2. Implications for Crohn's disease. J. Biol. Chem. 278 (2003) 5509-5512
11. Park J.H., Kim Y.G., McDonald C., Kanneganti T.D., Hasegawa M., Body-Malapel M., Inohara N., and Nunez G. RICK/RIP2 mediates innate immune responses induced through Nod1 and Nod2 but not TLRs. J. Immunol. 178 (2007) 2380-2386
12. Hayden M.S., and Ghosh S. Shared principles in NF-kB signaling. Cell 132 (2008) 344-362
13. Windheim M., Lang C., Peggie M., Plater L.A., and Cohen P. Molecular mechanisms involved in the regulation of cytokine production by muramyl dipeptide. Biochem. J. 404 (2007) 179-190
14. Yang Y., Yin C., Pandey A., Abbott D., Sassetti C., and Kelliher M.A. NOD2 pathway activation by MDP or Mycobacterium tuberculosis infection involves the stable polyubiquitination of Rip2. J. Biol. Chem. 282 (2007) 36223-36229
15. Hasegawa M., Fujimoto Y., Lucas P.C., Nakano H., Fukase K., Núñez G., and Inohara N. A critical role of RICK/RIP2 polyubiquitination in Nod-induced NF-kappaB activation. EMBO J. 27 (2007) 373-383
16. Bhoj V.G., and Chen Z.J. Ubiquitylation in innate and adaptive immunity. Nature 458 (2009) 430-437
17. Hustad C.M., Perry W.L., Siracusa L.D., Rasberry C., Cobb L., et al. Molecular genetic characterization of six recessive viable alleles of the mouse agouti locus. Genetics 140 (1995) 255-265
18. Perry W.L., Hustad C.M., Swing D.A., O'Sullivan T.N., Jenkins N.A., and Copeland N.G. The itchy locus encodes a novel ubiquitin protein ligase that is disrupted in a18H mice. Nat. Genet. 18 (1998) 143-146
19. Angers A., Ramjaun A.R., and McPherson P.S. The HECT domain ligase itch ubiquitinates endophilin and localizes to the trans-Golgi network and endosomal system. J. Biol. Chem. 279 (2004) 11471-11479
20. Matesic L.E., Copeland N.G., and Jenkins N.A. Itchy mice: the identification of a new pathway for the development of autoimmunity. Curr. Top. Microbiol. Immunol. 321 (2008) 185-200
21. Shembade N., Harhaj N.S., Parvatiyar K., Copeland N.G., Jenkins N.A., Matesic L.E., and Harhaj E.W. The E3 ligase Itch negatively regulates inflammatory signaling pathways by controlling the function of the ubiquitin-editing enzyme A20. Nat. Immunol. 9 (2008) 254-262
22. Song H.Y., Régnier C.H., Kirschning C.J., Goeddel D.V., and Rothe M. Tumor necrosis factor (TNF)-mediated kinase cascades: bifurcation of nuclear factor-kappaB and c-jun N-terminal kinase (JNK/SAPK) pathways at TNF receptor-associated factor 2. Proc. Natl. Acad. Sci. USA 94 (1997) 9792-9796
23. Häcker H., Redecke V., Blagoev B., Kratchmarova I., Hsu L.C., Wang G.G., Kamps M.P., Raz E., Wagner H., Häcker G., et al. Specificity in Toll-like receptor signalling through distinct effector functions of TRAF3 and TRAF6. Nature 439 (2006) 204-207
24. Oganesyan G., Saha S.K., Guo B., He J.Q., Shahangian A., Zarnegar B., Perry A., and Cheng G. Critical role of TRAF3 in the Toll-like receptor-dependent and -independent antiviral response. Nature 439 (2006) 208-211
25. Takeshita F., Ishii K.J., Kobiyama K., Kojima Y., Coban C., Sasaki S., Ishii N., Klinman D.M., Okuda K., Akira S., and Suzuki K. TRAF4 acts as a silencer in TLR-mediated signaling through the association with TRAF6 and TRIF. Eur. J. Immunol. 35 (2005) 2477-2485
26. Chastagner P., Israël A., and Brou C. Itch/AIP4 mediates Deltex degradation through the formation of K29-linked polyubiquitin chains. EMBO Rep. 7 (2006) 1147-1153
27. Scialpi F., Malatesta M., Peschiaroli A., Rossi M., Melino G., and Bernassola F. Itch self-polyubiquitylation occurs through lysine-63 linkages. Biochem. Pharmacol. 76 (2008) 1515-1521
28. Wertz I.E., O'Rourke K.M., Zhou H., Eby M., Aravind L., Seshagiri S., Wu P., Wiesmann C., Baker R., Boone D.L., et al. De-ubiquitination and ubiquitin ligase domains of A20 downregulate NF-kappaB signalling. Nature 430 (2004) 694-699
29. Hitotsumatsu O., Ahmad R.C., Tavares R., Wang M., Philpott D., Turer E.E., Lee B.L., Shiffin N., Advincula R., Malynn B.A., et al. The ubiquitin-editing enzyme A20 restricts nucleotide-binding oligomerization domain containing 2-triggered signals. Immunity 28 (2008) 381-390
30. Hutti J.E., Turk B.E., Asara J.M., Ma A., Cantley L.C., and Abbott D.W. IkappaB kinase beta phosphorylates the K63 deubiquitinase A20 to cause feedback inhibition of the NF-kappaB pathway. Mol. Cell. Biol. 27 (2007) 7451-7461
31. Kim Y.G., Park J.H., Shaw M.H., Franchi L., Inohara N., and Núñez G. The cytosolic sensors Nod1 and Nod2 are critical for bacterial recognition and host defense after exposure to Toll-like receptor ligands. Immunity 28 (2008) 246-257
32. Herskovits A.A., Auerbuch V., and Portnoy D.A. Bacterial ligands generated in a phagosome are targets of the cytosolic innate immune system. PLoS Pathog. 3 (2007) e51
33. Leber J.H., Crimmins G.T., Raghavan S., Meyer-Morse N.P., Cox J.S., and Portnoy D.A. Distinct TLR- and NLR-mediated transcriptional responses to an intracellular pathogen. PLoS Pathog. 4 (2008) e6
34. Gutierrez O., Pipaon C., Inohara N., Fontalba A., Ogura Y., Prosper F., Nunez G., and Fernandez-Luna J.L. Induction of Nod2 in myelomonocytic and intestinal epithelial cells via nuclear factor-kappa B activation. J. Biol. Chem. 277 (2002) 41701-41705
35. Bertrand, M.J., Doiron, K., Labbé, K., Korneluk, R.G., Barker, P.A., and Saleh, M. (2009). Cellular Inhibitors of Apoptosis cIAP1 and cIAP2 Are Required for Innate Immunity Signaling by the Pattern Recognition Receptors NOD1 and NOD2 (Immunity) ([Epub May 20 ahead of print]).
36. Inohara N., Koseki T., del Peso L., Hu Y., Yee C., et al. Nod1, an Apaf-1-like activator of caspase-9 and nuclear factor-kB. J. Biol. Chem. 274 (1999) 14560-14567
37. Clark N.M., Marinis J.M., Cobb B.A., and Abbott D.W. MEKK4 sequesters RIP2 to dictate NOD2 signal specificity. Curr. Biol. 18 (2008) 1402-1408
38. Marina-García N., Franchi L., Kim Y.G., Miller D., McDonald C., Boons G.J., and Núñez G. Pannexin-1-mediated intracellular delivery of muramyl dipeptide induces caspase-1 activation via cryopyrin/NLRP3 independently of Nod2. J. Immunol. 180 (2008) 4050-4057
39. Du P., Kibbe W.A., and Lin S.M. lumi: a pipeline for processing Illumina microarray. Bioinformatics 24 (2008) 1547-1548
40. Eisen M.B., Spellman P.T., Brown P.O., and Botstein D. Cluster analysis and display of genome-wide expression patterns. Proc. Natl. Acad. Sci. USA 95 (1998) 14863-14868